NIMH Names New Director

Joshua Gordon of Columbia University Medical Center will lead the National Institute of Mental Health.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NIHThe National Institute of Mental Health (NIMH) has named psychiatrist Joshua Gordon of Columbia University Medical Center in New York City its next director. Gordon, who succeeds past NIMH Director Thomas Insel, who left the agency to join Google Life Sciences last September. Gordon is expected to take the reins from interim NIMH Director Bruce Cuthbert next month, according to a National Institutes of Health (NIH) announcement.

“Josh is a visionary psychiatrist and neuroscientist with deep experience in mental health research and practice,” NIH Director Francis Collins said in the statement. “He is exceptionally well qualified to lead the NIMH research agenda to improve mental health and treatments for mental illnesses.”

In addition to seeing patients at Columbia, Gordon also studies mouse models with psychiatric disease–associated mutations. “Josh is certainly coming from a basic science side,” Carrie Bearden, a neuroscientist at the University of California, Los Angeles, told Science. “He really cares about taking the findings in the animal models and looking how it’s really convergent with patient findings.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies